Cathie Wood's position in Pacific Biosciences of California is currently worth $250 Million. That's 1.63% of their equity portfolio (18th largest holding). The investor owns 11.02% of the outstanding Pacific Biosciences of California stock. The first Pacific Biosciences of California trade was made in Q3 2017. Since then Cathie Wood bought shares eighteen more times and sold shares on eight occasions. The investor's estimated purchase price is $339 Million, resulting in a loss of 26%.
Noticias bolsa EEUU - Cathie Wood, fundadora de Ark Invest, ha desinvertido en Roku y Robinhood para apostar otros 6 millones de dólares en Pacific Bioscienc...
On Monday, August 7, 2023, Cathie Wood -led Ark Invest made significant trades, with the most notable being a substantial acquisition of shares in Pacific Bi...
Source: motorolka / Shutterstock.com Various biotech stocks are in focus today, but Pacific Biosciences (NASDAQ: PACB ) is one of the more notable names inve...
In this article, we discuss the 5 small-cap stock picks of Cathie Wood’s 2022 portfolio. If you want to read our analysis of Wood’s hedge fund performance, g...